Di Noto R, Scalia G, Abate G, Gorrese M, Pascariello C, Raia M, Morabito P, Capone F, Pardo C Lo, Mirabelli P, Mariotti E, Del Vecchio L
Dipartimento di Biochimica e Biotecnologie Mediche, Università Federico II and CEINGE Biotecnologie Avanzate, Naples, Italy.
Leuk Res. 2008 Aug;32(8):1196-9. doi: 10.1016/j.leukres.2007.12.016. Epub 2008 Feb 11.
Among histological aggressive non-Hodgkin lymphomas (NHL), the overall risk of central nervous system (CNS) relapse is approximately 5%, a figure which is too low to offer prophylaxis to all patients. The aim of this work is to demonstrate the utility of flow cytometry (FCM) in detecting occult leptomeningeal disease in this subtype of NHL. We studied cerebrospinal fluid (CSF) involvement in 42 newly diagnosed aggressive NHL patients at risk for CNS involvement. We used multicolour FCM to detect CSF infiltrating neoplastic cells. Among the 42 patients studied, 11 had CSF involvement as detected by FCM. Of these, only four were also positive for conventional morphology (p=0.046). These results designate that FCM as the first choice technique in NHL CSF clinical cell analysis.
在组织学上具有侵袭性的非霍奇金淋巴瘤(NHL)中,中枢神经系统(CNS)复发的总体风险约为5%,这一数字过低,无法对所有患者进行预防。这项工作的目的是证明流式细胞术(FCM)在检测这种NHL亚型中隐匿性软脑膜疾病方面的实用性。我们研究了42例新诊断的有CNS受累风险的侵袭性NHL患者的脑脊液(CSF)受累情况。我们使用多色FCM检测CSF中浸润的肿瘤细胞。在研究的42例患者中,有11例通过FCM检测到CSF受累。其中,只有4例在传统形态学检查中也呈阳性(p=0.046)。这些结果表明,FCM是NHL脑脊液临床细胞分析的首选技术。